Trial
NCT00529113
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Biogen
Collaborators
—
Condition
Pancreatic Neoplasms
Intervention
Bardoxolone methyl
Why stopped
To pursue other indications
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29